Concepedia

Impact of FGFR2 gene fusions on survival of patients with intrahepatic cholangiocarcinoma following curative intent resection

EeeLN H. Buckarma, Gabriel De La Cruz, Mark J. Truty, David M. Nagorney, Sean P. Cleary, Michael L. Kendrick, Mitesh J. Borad, Rondell P. Graham, Gregory J. Gores, Rory L. Smoot

HPB · 2022 · 10 citations · 15 references

DOI

Concepts

References

15

Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study

Ghassan K. Abou‐Alfa, Vaibhav Sahai, Antoine Hollebecque et al. · The Lancet Oncology · 2020 · 1.6K citations · Full text

, , +11

Genomic spectra of biliary tract cancer

Hiromi Nakamura, Yasuhito Arai, Yasushi Totoki et al. · Nature Genetics · 2015 · 1.3K citations

, , +14

Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study

Ghassan K. Abou‐Alfa, Teresa Macarulla, Milind Javle et al. · The Lancet Oncology · 2020 · 1.1K citations · Full text

, , +8

Intrahepatic Cholangiocarcinoma: An International Multi-Institutional Analysis of Prognostic Factors and Lymph Node Assessment

Mechteld C. de Jong, Hari Nathan, Georgios C. Sotiropoulos et al. · Journal of Clinical Oncology · 2011 · 746 citations · Full text

, , +17

Identification of Targetable FGFR Gene Fusions in Diverse Cancers

Yi-Mi Wu, Fengyun Su, Shanker Kalyana‐Sundaram et al. · Cancer Discovery · 2013 · 738 citations · Full text

, , +12